Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for InspireMD, Inc. (NSPR : NSDQ)
 
 • Company Description   
InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel.

Number of Employees: 48

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.21 Daily Weekly Monthly
20 Day Moving Average: 203,001 shares
Shares Outstanding: 7.91 (millions)
Market Capitalization: $41.19 (millions)
Beta: 1.85
52 Week High: $22.20
52 Week Low: $4.23
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -1.14% -2.21%
12 Week -48.31% -51.59%
Year To Date 1.94% -9.74%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4 MENORAT HAMAOR ST.
-
TEL AVIV,L3 6744832
ISR
ph: 888-776-6204
fax: -
craigs@inspiremd.com http://www.inspire-md.com
 
 • General Corporate Information   
Officers
Marvin Slosman - President; Chief Executive Officer and Director
Paul Stuka - Chairman of the Board of Directors
Craig Shore - Chief Financial Officer; Chief Administrative Offi
Michael Berman - Director
Campbell Rogers - Director

Peer Information
InspireMD, Inc. (ABMD)
InspireMD, Inc. (DMDS)
InspireMD, Inc. (CPWY.)
InspireMD, Inc. (EQUR)
InspireMD, Inc. (ECIA)
InspireMD, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 45779A846
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/21
Next Expected EPS Date: 08/04/21
Share - Related Items
Shares Outstanding: 7.91
Most Recent Split Date: 4.00 (0.07:1)
Beta: 1.85
Market Capitalization: $41.19 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/21  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.93
Price/Cash Flow: -
Price / Sales: 16.77
EPS Growth
vs. Year Ago Period: 91.78%
vs. Previous Quarter: 64.65%
Sales Growth
vs. Year Ago Period: -2.71%
vs. Previous Quarter: 536.71%
ROE
03/31/21 - -58.60
12/31/20 - -105.09
09/30/20 - -110.91
ROA
03/31/21 - -47.35
12/31/20 - -72.08
09/30/20 - -73.09
Current Ratio
03/31/21 - 16.14
12/31/20 - 4.14
09/30/20 - 5.19
Quick Ratio
03/31/21 - 15.72
12/31/20 - 3.76
09/30/20 - 4.65
Operating Margin
03/31/21 - -480.63
12/31/20 - -424.31
09/30/20 - -276.89
Net Margin
03/31/21 - -480.63
12/31/20 - -424.31
09/30/20 - -276.89
Pre-Tax Margin
03/31/21 - -480.46
12/31/20 - -424.14
09/30/20 - -276.17
Book Value
03/31/21 - 5.59
12/31/20 - 2.00
09/30/20 - 5.07
Inventory Turnover
03/31/21 - 1.90
12/31/20 - 1.78
09/30/20 - 2.00
Debt-to-Equity
03/31/21 - 0.00
12/31/20 - 0.00
09/30/20 - 0.00
Debt-to-Capital
03/31/21 - 0.00
12/31/20 - 0.00
09/30/20 - 0.00
 

Powered by Zacks Investment Research ©